TCF7 and thyroid gland carcinoma: However, studies have also shown that METTL3 can induce the m6A mRNA modification of TCF1, a downstream effector of the classical Wnt pathway encoded by TCF7, by activating the Wnt pathway, thereby accelerating the progression of thyroid cancer (Wang et al., 2020c).